Jinwon Life Sciences ranked among the top searched stocks for 15 days in the past month.
As of 9:30 AM on the 1st, Jinwon Life Sciences is trading at 26,050 KRW, down 3.52% from the previous day. This represents a 7.46% decline compared to November 3. Jinwon Life Sciences is known as a specialized company in gene therapy and gene vaccine development.
Over the past 5 days, individual investors have net sold 12,000 shares, while foreigners and institutions have net bought 10,766 shares and 24,143 shares, respectively.
On November 30, Jinwon Life Sciences became a market issue with the headline "COVID-19 Treatment FDA Phase 2 Clinical Trial Approval Surge."
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
